The head of Thyssenkrupp's steel unit, Dennis Grimm, has decided to leave the division, two people familiar with the matter said on Tuesday. ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Lowe's (LOW) .Lowe's currently has an average brokerage recommend ...

Labcorp Holdings (LH) reported $3.56 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 8.6%. EPS of $4.18 for the same period compares to $3.50 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $3.56 billion, representing a surprise of -0.01%. The company delivered an EPS surprise of +1.21%, with the consensus EPS estimate being $4.13.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...

For the quarter ended September 2025, V.F. (VFC) reported revenue of $2.8 billion, up 1.6% over the same period last year. EPS came in at $0.52, compared to $0.60 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $2.73 billion, representing a surprise of +2.72%. The company delivered an EPS surprise of +23.81%, with the consensus EPS estimate being $0.42.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expecta ...

Incyte (INCY) reported $1.37 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 20.1%. EPS of $2.26 for the same period compares to $1.07 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.26 billion, representing a surprise of +8.71%. The company delivered an EPS surprise of +36.14%, with the consensus EPS estimate being $1.66.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

For the quarter ended September 2025, Southern First (SFST) reported revenue of $31.13 million, up 31% over the same period last year. EPS came in at $1.07, compared to $0.54 in the year-ago quarter.The reported revenue represents a surprise of +4.25% over the Zacks Consensus Estimate of $29.86 million. With the consensus EPS estimate being $0.89, the EPS surprise was +20.22%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...

Sherwin-Williams (SHW) reported $6.36 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 3.2%. EPS of $3.59 for the same period compares to $3.37 a year ago.The reported revenue represents a surprise of +2.37% over the Zacks Consensus Estimate of $6.21 billion. With the consensus EPS estimate being $3.46, the EPS surprise was +3.76%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Eli Lilly (LLY), and highlights the potential misalignment of interests between brokerage firms and retail investors [1][10]. Brokerage Recommendations - Eli Lilly currently has an average brokerage recommendation (ABR) of 1.55, indicating a consensus between Strong Buy and Buy, based on recommendations from 28 brokerage firms [2]. - Out of the 28 recommendations, 19 are classified as Strong Buy, accounting for 67.9%, while 2 are classified as Buy, making up 7.1% of the total [2]. Limitations of Brokerage Recommendations - The article suggests that relying solely on brokerage recommendations may not be wise, as studies indicate limited success in guiding investors towards stocks with the best price increase potential [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, often issuing five "Strong Buy" recommendations for every "Strong Sell" [6][10]. Zacks Rank as an Alternative - Zacks Rank is presented as a more effective tool for predicting stock price movements, categorizing stocks into five groups based on earnings estimate revisions [8][11]. - The Zacks Rank is distinct from ABR, as it is based on quantitative models rather than solely on brokerage recommendations, and is updated more frequently to reflect current market conditions [9][12]. Current Earnings Estimates for Eli Lilly - The Zacks Consensus Estimate for Eli Lilly's current year earnings has declined by 1.8% over the past month to $22.73, indicating growing pessimism among analysts regarding the company's earnings prospects [13]. - This decline in earnings estimates has resulted in a Zacks Rank of 4 (Sell) for Eli Lilly, suggesting caution despite the positive ABR [14].

Core Insights - The 2025 Edition of Remus Gatsby Reserve 15-Year Bourbon is launched to commemorate the 100th anniversary of "The Great Gatsby" by F. Scott Fitzgerald, featuring a cask strength of 102.8 proof (51.4% ABV) and a retail price of $199.99 per 750mL bottle [1][2][3] Product Details - The bourbon is crafted from a historic 21% rye mash bill and showcases flavors of cherry, vanilla, and oak, with a finish of toasted oak and cherry [3][4] - The packaging is inspired by Art Deco design, reflecting the 1920s aesthetic, and includes interactive elements like a QR code for a themed celebration [4] Awards and Recognition - The Remus Gatsby Reserve has received multiple prestigious awards, including platinum and double platinum medals at the ASCOT Awards and recognition as one of the "50 Greatest Bourbons" by the Robb Report [5] Company Background - Ross & Squibb Distillery, part of Luxco, is known for producing high-quality bourbon and operates several distilleries, including those in Indiana and Kentucky [7][8]